Oral Reserpine Administration Results in Low Plasma Concentrations That Alter Equine Platelet Biology and Can Affect the Generation of Biologic Products from Equine Patients. Jessica M. Gilbertie1, Jennifer L. Davis2, Lauren V. Schnabel1. 1NC State University College of Veterinary Medicine, Department of Clinical Sciences, Raleigh, NC; 2VA-MD College of Veterinary Medicine, Blacksburg, VA
Assistant Professor of Equine Orthopedic Surgery
North Carolina State University
Dr. Lauren Schnabel, DVM, Ph.D., Diplomate ACVS-LA, and Diplomate ACVSMR-Equine is an assistant professor of orthopedic surgery at North Carolina State University.
Dr. Schnabel grew up in New York where she enjoyed spending time around both sport horses and racehorses. After receiving her bachelor degree from Duke University, she attended Cornell University for her veterinary degree. She then completed an internship at Rood and Riddle Equine Hospital before returning to Cornell as a postdoctoral fellow in the Laboratories of Dr. Lisa Fortier and Dr. Alan Nixon where she performed research on tendon and ligament repair. Dr. Schnabel completed her surgical residency at Cornell from 2006-2009 and became a Diplomate of the ACVS in 2010. She then completed her Ph.D. with Dr. Fortier on the immunologic properties of stem cells.
Dr. Schnabel began her position at NC State in 2013 working in both the equine hospital and her research laboratory. She specializes in the use of regenerative therapies for the treatment of musculoskeletal injuries and has published and given lectures both nationally and internationally on platelet-rich plasma, bone marrow aspirate concentrate, and stem cells. In particular, her laboratory is focused on understanding the immunologic and immunomodulatory properties of mesenchymal stem cells. Such knowledge is critical for potential allogeneic “off the shelf” stem cell therapy which would allow us to treat patients at the time of diagnosis rather than having to wait several weeks to months to culture stem cells from that patient. Her laboratory is also actively investigating the novel use of platelet-rich plasma lysate for the treatment of infectious arthritis in collaboration with Dr. Tom Schaer at Penn Vet.
At NC State, Dr. Schnabel runs the Clinical Mesenchymal Stem Cell Culture Service and is developing the Sports Medicine and Rehabilitation Service at with Dr. Rich Redding and colleagues.
Friday, October 13
11:00 AM – 11:15 AM
Friday, October 13
3:00 PM – 3:15 PM
Saturday, October 14
8:00 AM – 9:15 AM
The asset you are trying to access is locked. Please enter your access key to unlock.